Samenvatting
PMLRAR (retinoic acid receptor)α is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML-RARα target genes, its interplay with RXR and deregulation of epigenetic modifications.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 554-558 |
Aantal pagina's | 5 |
Tijdschrift | British Journal of Cancer |
Volume | 104 |
Nummer van het tijdschrift | 4 |
DOI's | |
Status | Gepubliceerd - 15 feb. 2011 |
Extern gepubliceerd | Ja |